Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leiv Ose

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Acta Obstetricia Et Gynecologica Scandinavica|October 31, 2008
Evidence for impaired physiological decrease in the uteroplacental vascular resistance in pregnant women with familial hypercholesterolemiaJanette Khoury, Agot L Amundsen, Serena Tonstad, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 27, 2002
[Guidelines for pharmacological primary prevention of cardiovascular diseases--who should be treated?]Atle Fretheim, Arild Bjørndal, Andrew D Oxman, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 27, 2002
[Which antihypertensive drugs should be used in the primary prevention of cardiovascular disease?]Atle Fretheim, Arild Bjørndal, Andrew D Oxman, et al.
Scandinavian Cardiovascular Journal : SCJ|July 20, 2010
HypoCol (red yeast rice) lowers plasma cholesterol - a randomized placebo controlled studyMartin Prøven Bogsrud, Leiv Ose, Gisle Langslet, et al.
Atherosclerosis|March 8, 2011
Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemiaMarit S Nenseter, Henriette Walaas Lindvig, Thor Ueland, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 27, 2002
[Which cholesterol-lowering drugs should be used in the primary prevention of cardiovascular disease?]Atle Fretheim, Arild Bjørndal, Andrew D Oxman, et al.
European Journal of Preventive Cardiology|November 1, 2016
Cardiovascular disease mortality in patients with genetically verified familial hypercholesterolemia in Norway during 1992-2013Liv Mundal, Jannicke Igland, Leiv Ose, et al.
Current Medical Research and Opinion|May 20, 2006
Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysisLeiv Ose, Arvind Shah, Michael J Davies, et al.
The Journal of Nutrition|October 22, 2008
The antiatherogenic function of HDL is impaired in hyperhomocysteinemic subjectsKirsten B Holven, Pål Aukrust, Kjetil Retterstøl, et al.
The British Journal of Nutrition|August 18, 2009
Cystatin C levels in plasma and peripheral blood mononuclear cells among hyperhomocysteinaemic subjects: effect of treatment with B-vitaminsKari Anne R Tobin, Kirsten B Holven, Kjetil Retterstøl, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Acta Obstetricia Et Gynecologica Scandinavica|October 31, 2008
Evidence for impaired physiological decrease in the uteroplacental vascular resistance in pregnant women with familial hypercholesterolemiaJanette Khoury, Agot L Amundsen, Serena Tonstad, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 27, 2002
[Guidelines for pharmacological primary prevention of cardiovascular diseases--who should be treated?]Atle Fretheim, Arild Bjørndal, Andrew D Oxman, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 27, 2002
[Which antihypertensive drugs should be used in the primary prevention of cardiovascular disease?]Atle Fretheim, Arild Bjørndal, Andrew D Oxman, et al.
Scandinavian Cardiovascular Journal : SCJ|July 20, 2010
HypoCol (red yeast rice) lowers plasma cholesterol - a randomized placebo controlled studyMartin Prøven Bogsrud, Leiv Ose, Gisle Langslet, et al.
Atherosclerosis|March 8, 2011
Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemiaMarit S Nenseter, Henriette Walaas Lindvig, Thor Ueland, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 27, 2002
[Which cholesterol-lowering drugs should be used in the primary prevention of cardiovascular disease?]Atle Fretheim, Arild Bjørndal, Andrew D Oxman, et al.
European Journal of Preventive Cardiology|November 1, 2016
Cardiovascular disease mortality in patients with genetically verified familial hypercholesterolemia in Norway during 1992-2013Liv Mundal, Jannicke Igland, Leiv Ose, et al.
Current Medical Research and Opinion|May 20, 2006
Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysisLeiv Ose, Arvind Shah, Michael J Davies, et al.
The Journal of Nutrition|October 22, 2008
The antiatherogenic function of HDL is impaired in hyperhomocysteinemic subjectsKirsten B Holven, Pål Aukrust, Kjetil Retterstøl, et al.
The British Journal of Nutrition|August 18, 2009
Cystatin C levels in plasma and peripheral blood mononuclear cells among hyperhomocysteinaemic subjects: effect of treatment with B-vitaminsKari Anne R Tobin, Kirsten B Holven, Kjetil Retterstøl, et al.
Pageof 8